Humacyte, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
HUMA, HUMAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2525 East North Carolina Highway 54, Durham, NC

Insiders trading volume in the past year

Humacyte, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ayabudge LLC 10%+ Owner $9.75M Aug 17, 2023
Laura E. Niklason President, CEO and Director, Director $2.2M -$10.3M -82.4% Aug 18, 2025
Brady W. Dougan Director $2.2M -$10.3M -82.4% Aug 18, 2025
Gordon M. Binder Director $1.41M May 15, 2024
Kathleen Sebelius Director $120K +$66K +121% Jun 12, 2025
Dale A. Sander CFO and Chief Corp. Deve. Off. $65.2K +$30.6K +88.5% Apr 10, 2025
William Edward Tente Chief Regulatory Officer $62.5K Aug 26, 2021
Michael T. Constantino Director $41.5K +$40.3K +3430% Jun 12, 2025
William John Scheessele Chief Commercial Officer $33.9K +$10K +41.8% Apr 14, 2025
Shamik J. Parikh Chief Medical Officer $11.6K +$11.6K Apr 10, 2025
Charles Bruce Green Director $10.8K +$7.74K +250% Jun 12, 2025
Jeffrey Harold Lawson Chief Surgical Officer, Director $9.37K Aug 26, 2021
Heather Ledbetter Prichard Chief Operating Officer $0 Jan 21, 2025
Kiernan Thomas DeAngelis Chief Medical Officer Aug 26, 2021
Rajiv Shukla Director Jun 15, 2023
Diane Seimetz Director Jun 12, 2025
Max N. Wallace Director Jun 12, 2025
Fresenius Medical Care Holdings Inc /Ny/ 10%+ Owner Aug 26, 2021
Susan Richards Windham-Bannister Director Jun 12, 2025
Yang Cao Chief Regulatory Officer Jan 21, 2025
Emery N. Brown Director Jun 12, 2025
Keith Anthony Jones Director Jun 12, 2025
John Philip Bamforth Director Jun 12, 2025
Todd Pope Director Jun 12, 2025

Recent Insider Transactions by Companies or Individuals for Humacyte, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.